Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)

NCT03137303 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT03137303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03137303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)
Lead sponsor
University of Illinois at Chicago
Phase
Phase 3
Overall status
Completed
Start date
July 1, 2017
Completion date
September 30, 2019
Enrollment
402 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

copd asthma